Li Li, PhD, is a Professor in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine, University of California, Los Angeles (UCLA). She served as the Director of the Methods Core at the Center for HIV Identification, Prevention, and Treatment Services (CHIPTS) from 2004 to 2021. Dr. Li’s research focuses on HIV and drug addiction prevention and treatment and the social determinants of health. She has led multiple NIH-funded randomized controlled trials aimed at reducing HIV-related stigma among service providers and improving HIV and addiction treatment outcomes in China and Vietnam, and enhancing the quality of life for families and children impacted by HIV in Thailand and China. Her work has contributed to building the capacity of community health workers in delivering HIV and addiction services in Vietnam. Over the past 20 years, Dr. Li has been actively involved in UCLA’s Fogarty training programs.

1. Li, L., Yuan, D., Zhao, F., Shen, Y., Cui, C., Moog, C., Sun, L., Wang, B., Liu, L., Zhang, T., & Su, B. (2025). HIV-1 drug resistance and molecular transmission network analysis of newly diagnosed people living with HIV in Beijing, China: a retrospective study from 2015 to 2023. Virology journal, 22(1), 366.

2. Feng, L., Wang, Y., Li, L., Wang, X., & Feng, J. (2025). Global burden of HIV and drug-resistant tuberculosis co-infection and its attributable risk factors, 1990 to 2021, with projections to 2031. BMC infectious diseases, 25(1), 1521.

3. Nguyen, H. N., Li, L., Nguyen, V. T., Nguyen, D. B., Phan, T. D., & Pham, T. H. (2025). Perceived Barriers to Care Among People Who Use Drugs in Vietnam. Drug and alcohol review, 10.1111/dar.70054. Advance online publication.

Last updated: 11/20/2025